Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity

The occurrence of obesity is an increasing issue worldwide, especially in industrialized countries. Weight loss is important both to treat obesity and to prevent the development of complications. Currently, several drugs are used to treat obesity, but their efficacy is modest. Thus, new anti-obesity...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaffina, Isabella, Pelle, Maria Chiara, Armentaro, Giuseppe, Giofrè, Federica, Cassano, Velia, Sciacqua, Angela, Arturi, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992880/
https://www.ncbi.nlm.nih.gov/pubmed/36909312
http://dx.doi.org/10.3389/fendo.2023.1095753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992880/
https://www.ncbi.nlm.nih.gov/pubmed/36909312
http://dx.doi.org/10.3389/fendo.2023.1095753

Ejemplares similares